| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/2004 | EP1441729A1 Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor |
| 08/04/2004 | EP1441728A2 Modulators of the cholesterol biosynthetic pathway |
| 08/04/2004 | EP1441727A1 Depot formulations of iloperidone and a star polymer |
| 08/04/2004 | EP1441726A1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441724A1 Methods of increasing endogenous testosterone levels |
| 08/04/2004 | EP1441723A1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 08/04/2004 | EP1441722A2 Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 08/04/2004 | EP1441721A2 Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 08/04/2004 | EP1441720A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 08/04/2004 | EP1441719A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441717A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 08/04/2004 | EP1441716A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions |
| 08/04/2004 | EP1441715A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 08/04/2004 | EP1441714A2 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 08/04/2004 | EP1441713A1 Modified release tamsulosin tablets |
| 08/04/2004 | EP1441712A2 Reversing or preventing premature vascular senescence |
| 08/04/2004 | EP1441711A1 Treatment of breast cancer |
| 08/04/2004 | EP1441710A1 Use of n,n-diethyl-2- -4-(phenylmethyl)-phenoxy ethanamine monohydrochloride (dppe) in cancer therapy |
| 08/04/2004 | EP1441709A1 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 08/04/2004 | EP1441708A1 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 08/04/2004 | EP1441707A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
| 08/04/2004 | EP1441706A2 Antimuscarinic aerosol |
| 08/04/2004 | EP1441705A1 Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs |
| 08/04/2004 | EP1441702A2 Method for treating primary insomnia |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441700A1 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 08/04/2004 | EP1441698A1 Flashmelt oral dosage formulation |
| 08/04/2004 | EP1441697A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 08/04/2004 | EP1441696A1 Method and composition for dry eye treatment |
| 08/04/2004 | EP1441694A1 Gastric raft composition |
| 08/04/2004 | EP1441693A1 Skin preparation comprising a tocopherol derivative for external application |
| 08/04/2004 | EP1441685A2 Anti-irritating rosacea treatment |
| 08/04/2004 | EP1441684A2 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524 |
| 08/04/2004 | EP1441683A2 Trisubstituted triazine compounds, and methods for making an using the compounds, which have antitubulin activity |
| 08/04/2004 | EP1441682A1 Method to induce neovascular formation and tissue regeneration |
| 08/04/2004 | EP1441667A1 Improved endoprosthetic device |
| 08/04/2004 | EP1441635A2 Sterile, breathable patch for treating wound pain |
| 08/04/2004 | EP1401275A4 Antiviral composition and treatment method |
| 08/04/2004 | EP1370148A4 Anticholesterolemic edible oil |
| 08/04/2004 | EP1368027B1 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors |
| 08/04/2004 | EP1337528B1 Benzothiophene derivative compounds, process of preparation and use thereof |
| 08/04/2004 | EP1337236B1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 08/04/2004 | EP1296945B1 Sulfonamide derivatives |
| 08/04/2004 | EP1296675B1 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 08/04/2004 | EP1294380B1 A method for treating septic shock |
| 08/04/2004 | EP1292586B1 Process for the preparation of pyrazolopyrimidinones |
| 08/04/2004 | EP1289945B1 Aniline disulfide derivatives for treating allergic diseases |
| 08/04/2004 | EP1287003B1 Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
| 08/04/2004 | EP1280806B1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 08/04/2004 | EP1228032B1 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 08/04/2004 | EP1202730B1 Use of ep4 receptor ligands in the treatment of neuropathic pain |
| 08/04/2004 | EP1200444B1 Novel xanthone compounds, their preparation and use as medicament |
| 08/04/2004 | EP1196155B1 New use of compounds as antibacterial agents |
| 08/04/2004 | EP1192131B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 08/04/2004 | EP1171151A4 Thrombospondin-2 and uses thereof |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1165600B1 Proteins modified by xanthurenic acid |
| 08/04/2004 | EP1161157B1 Food complement and method for cosmetic treatment based on a grape extract rich in polyphenols |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1143968B9 Composition and methods for administration of water-insoluble paclitaxel derivatives |
| 08/04/2004 | EP1140903B1 Aromatic amides |
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1129212B1 Screening process for antibacterial agents |
| 08/04/2004 | EP1124829B1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 08/04/2004 | EP1123704B1 Remedies for spinal canal stenosis |
| 08/04/2004 | EP1112262B1 Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto |
| 08/04/2004 | EP1091956B1 Muscarinic antagonists |
| 08/04/2004 | EP1077957B1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 08/04/2004 | EP1076657B1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
| 08/04/2004 | EP1071745B1 Process for synthesizing cox-2 inhibitors |
| 08/04/2004 | EP1070714B1 Amidine compounds |
| 08/04/2004 | EP1064256B1 Bicyclo [2.2.1] heptanes and related compounds |
| 08/04/2004 | EP1029246B1 A method and device for preventing immunoglobulin degradation in external secretions |
| 08/04/2004 | EP1027093B1 Apparatus for applying 5-aminolevulinic acid |
| 08/04/2004 | EP0983069B1 USE OF TAUROLIDINE FOR the manufacture of a medicament for the TREATMENT OF LEUKEMIAS |
| 08/04/2004 | EP0961618B1 5-Pyrimidinyl-4-yl-Imidazole Derivate zur Behandlung von CSBP/RK/p38 vermittelten Erkrankungen |
| 08/04/2004 | EP0950059B1 Cyclic sulfone derivatives |
| 08/04/2004 | EP0934531B1 Diagnosis of spongiform encephalopathy |
| 08/04/2004 | EP0915899B1 Preparation of crystal form ii of clarithromycin |
| 08/04/2004 | EP0912571B1 Naphthyridines which affect il-4 and g-csf |
| 08/04/2004 | EP0873051B1 Modulation of calcium channels |
| 08/04/2004 | EP0740708B1 Design of drugs involving receptor-ligand-dna interactions |
| 08/04/2004 | EP0690671B1 Method and apparatus for encapsulation of biologically-active substances in cells |
| 08/04/2004 | EP0667772B9 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 08/04/2004 | CN1518598A Serpin in Bifidobacteria |
| 08/04/2004 | CN1518597A Novel fibroblast growth factors |
| 08/04/2004 | CN1518573A Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for preparation of the same |
| 08/04/2004 | CN1518567A Linear block polymer |
| 08/04/2004 | CN1518557A Novel 5-thio-beta-D-xylopyranoside derivatives, preparation meethod thereof, pharmaceutical compositions containing same and the therapeutic use thereof |
| 08/04/2004 | CN1518553A Beta-substituted befa-aminoethyl. phosphonates compound |
| 08/04/2004 | CN1518552A Pyrrolopyrimidines as protein kinase inhitibors |
| 08/04/2004 | CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 08/04/2004 | CN1518550A Imidazo [1,2-A] pyridine derivatives for prophylaxis and treatment of herpes viral infections |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518548A Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
| 08/04/2004 | CN1518547A Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |